AAAAAA

   
Results: 1-11 |
Results: 11
Immunostimulating complexes (ISCOMs) for nasal vaccination
Authors: Hu, KF Lovgren-Bengtsson, K Morein, B
Citation: Kf. Hu et al., Immunostimulating complexes (ISCOMs) for nasal vaccination, ADV DRUG DE, 51(1-3), 2001, pp. 149-159
In vivo and in vitro lipidation of recombinant immunogens for direct iscomincorporation
Authors: Andersson, C Wikman, M Lovgren-Bengtsson, K Lunden, A Stahl, S
Citation: C. Andersson et al., In vivo and in vitro lipidation of recombinant immunogens for direct iscomincorporation, J IMMUNOL M, 255(1-2), 2001, pp. 135-148
Impaired immunogenicity of immunostimulating complexes (iscoms) by administration in slow-release formulations
Authors: Johansson, M Ranlund, K Lovgren-Bengtsson, K
Citation: M. Johansson et al., Impaired immunogenicity of immunostimulating complexes (iscoms) by administration in slow-release formulations, MICROBES IN, 2(9), 2000, pp. 1003-1010
Introduction of the haemagglutinin transmembrane region in the influenza virus matrix protein facilitates its incorporation into ISCOM and activationof specific CD8(+) cytotoxic T lymphocytes
Authors: Voeten, JTM Rimmelzwaan, GF Nieuwkoop, NJ Lovgren-Bengtsson, K Osterhaus, ADME
Citation: Jtm. Voeten et al., Introduction of the haemagglutinin transmembrane region in the influenza virus matrix protein facilitates its incorporation into ISCOM and activationof specific CD8(+) cytotoxic T lymphocytes, VACCINE, 19(4-5), 2000, pp. 514-522
Improved systems for hydrophobic tagging of recombinant immunogens for efficient iscom incorporation
Authors: Andersson, C Sandberg, L Wernerus, H Johansson, M Lovgren-Bengtsson, K Stahl, S
Citation: C. Andersson et al., Improved systems for hydrophobic tagging of recombinant immunogens for efficient iscom incorporation, J IMMUNOL M, 238(1-2), 2000, pp. 181-193
The ISCOM (TM) technology
Authors: Lovgren-Bengtsson, K Morein, B
Citation: K. Lovgren-bengtsson et B. Morein, The ISCOM (TM) technology, METH MOL M, 42, 2000, pp. 239-258
Induction of antibody responses in the common mucosal immune system by respiratory syncytical virus immunostimulating complexes
Authors: Hu, KF Ekstrom, J Merza, M Lovgren-Bengtsson, K Morein, B
Citation: Kf. Hu et al., Induction of antibody responses in the common mucosal immune system by respiratory syncytical virus immunostimulating complexes, MED MICROBI, 187(4), 1999, pp. 191-198
The major Epstein-Barr virus (EBV) envelope glycoprotein gp340 when incorporated into Iscoms primes cytotoxic T-cell responses directed against EBV lymphoblastoid cell lines
Authors: Wilson, AD Lovgren-Bengtsson, K Villacres-Ericsson, M Morein, B Morgan, AJ
Citation: Ad. Wilson et al., The major Epstein-Barr virus (EBV) envelope glycoprotein gp340 when incorporated into Iscoms primes cytotoxic T-cell responses directed against EBV lymphoblastoid cell lines, VACCINE, 17(9-10), 1999, pp. 1282-1290
Iscoms with different quillaja saponin components differ in their immunomodulating activities
Authors: Johansson, M Lovgren-Bengtsson, K
Citation: M. Johansson et K. Lovgren-bengtsson, Iscoms with different quillaja saponin components differ in their immunomodulating activities, VACCINE, 17(22), 1999, pp. 2894-2900
General expression vectors for production of hydrophobically tagged immunogens for direct iscom incorporation
Authors: Andersson, C Sandberg, L Murby, M Sjolander, A Lovgren-Bengtsson, K Stahl, S
Citation: C. Andersson et al., General expression vectors for production of hydrophobically tagged immunogens for direct iscom incorporation, J IMMUNOL M, 222(1-2), 1999, pp. 171-182
ISCOM: A delivery system for neonates and for mucosal administration
Authors: Morein, B Villacres-Eriksson, M Ekstrom, J Hu, K Behboudi, S Lovgren-Bengtsson, K
Citation: B. Morein et al., ISCOM: A delivery system for neonates and for mucosal administration, ADV VETER M, 41, 1999, pp. 405-413
Risultati: 1-11 |